WuXi AppTec Co., Ltd.
General ticker "WUXIF" information:
- Sector: Health Care
- Industry: Medical - Diagnostics & Research
- Capitalization: $43.0B (TTM average)
WuXi AppTec Co., Ltd. follows the US Stock Market performance with the rate: 37.7%.
Estimated limits based on current volatility of 3.4%: low 25.59$, high 27.08$
Factors to consider:
- Company pays dividends (annually): last record date 2026-08-20, amount 0.08$ (Y0.31%)
- Current price 58.4% above estimated high
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [9.33$, 16.46$]
- 2026-12-31 to 2027-12-31 estimated range: [9.01$, 16.10$]
Financial Metrics affecting the WUXIF estimates:
- Positive: with PPE of 14.2 at the end of fiscal year the price was neutral
- Positive: Operating profit margin, % of 37.41 > 33.79
- Positive: 4.90 < Operating cash flow per share per price, % of 6.30
- Positive: 69.38 < Shareholder equity ratio, % of 77.30 <= 81.92
- Positive: Return on assets ratio (scaled to [-100,100]) of 15.79 > 10.70
- Positive: -16.84 < Industry operating profit margin (median), % of -16.21
- Negative: negative Industry operating cash flow (median)
- Positive: Industry inventory ratio change (median), % of 0.16 <= 0.47
- Positive: -1.23 < Investing cash flow per share per price, % of -0.71
- Negative: Inventory ratio change, % of 4.42 > 4.02
- Positive: Interest expense per share per price, % of 0.11 <= 0.33
Short-term WUXIF quotes
Long-term WUXIF plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | CNY40,340.81MM | CNY39,241.43MM | CNY45,456.17MM |
| Operating Expenses | CNY28,468.52MM | CNY27,661.26MM | CNY28,451.22MM |
| Operating Income | CNY11,872.29MM | CNY11,580.17MM | CNY17,004.94MM |
| Non-Operating Income | CNY-40.29MM | CNY-40.36MM | CNY6,901.21MM |
| Interest Expense | CNY74.82MM | CNY216.03MM | CNY306.49MM |
| R&D Expense | CNY1,440.63MM | CNY1,238.52MM | CNY1,119.45MM |
| Income(Loss) | CNY11,831.99MM | CNY11,539.81MM | CNY23,906.15MM |
| Taxes | CNY2,131.73MM | CNY1,972.07MM | CNY4,573.09MM |
| Net Income(Loss)* | CNY9,606.75MM | CNY9,450.31MM | CNY19,150.58MM |
| Stockholders Equity | CNY55,122.45MM | CNY58,632.71MM | CNY79,712.29MM |
| Inventory | CNY4,736.23MM | CNY5,399.75MM | CNY8,993.25MM |
| Assets | CNY73,669.35MM | CNY80,325.82MM | CNY103,120.97MM |
| Operating Cash Flow | CNY13,386.91MM | CNY12,406.51MM | CNY17,203.16MM |
| Capital expenditure | CNY5,516.56MM | CNY4,003.49MM | CNY5,538.15MM |
| Investing Cash Flow | CNY-7,560.53MM | CNY-5,518.18MM | CNY-1,945.11MM |
| Financing Cash Flow | CNY-3,941.38MM | CNY-3,832.19MM | CNY1,123.54MM |
| Earnings Per Share** | CNY3.24 | CNY3.28 | CNY6.70 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.